Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Etismith 0.25mg Tablet

Prescription Icon
Prescription Required

Marketer

Domagk Smith Labs Pvt Ltd

Salt Composition

Etizolam (0.25mg)

Overview Etismith 0.25mg Tablet

Anxiocalm 0.25mg tablets are a prescription medication for short-term relief of anxiety and sleeplessness. Working by binding to specific brain receptors, it promotes cerebral calmness and relaxation. Anxiocalm 0.25mg tablets can be administered with or without food, but consistent daily timing ensures stable blood levels. Always adhere to your physician's prescribed dosage and duration; this medication carries a significant risk of dependency. Missed doses should be taken immediately upon recall, completing the entire course even with symptom improvement. Discontinuing Anxiocalm 0.25mg tablets without consulting your doctor may trigger nausea and anxiety. Potential side effects include headaches, motor skill impairment, speech difficulties, muscle weakness, altered sex drive, and depression. Dizziness and drowsiness are also possible; avoid driving or mentally demanding tasks until the medication's effects are known. Discuss potential side effects and management strategies with your doctor; withdrawal effects may occur. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding before commencing treatment. While generally safe to combine with other medications, Anxiocalm 0.25mg tablets' efficacy may be altered by substances such as antacids and alcohol, increasing the likelihood of adverse reactions. Prolonged use may necessitate regular blood and liver function monitoring.

Uses of Etismith 0.25mg Tablet

Managing transient anxiety and sleeplessness.

Major Benefits of Etismith 0.25mg Tablet:

Administer Etismith 0.25mg Tablet as directed by your physician, ingesting the entire tablet without chewing, crushing, or dividing. Consumption may coincide with meals or be taken independently; however, consistent timing is recommended.

Common Side effects of Etismith 0.25mg Tablet:

  • Altered libido
  • Confusion
  • Depression
  • Drowsiness
  • Fainting
  • Headache
  • Muscle coordination impaired
  • Muscle weakness
  • Sedation
  • Slurred speech
  • Tremors
  • Visual impairment

How to use Etismith 0.25mg Tablet:

Consume Etismith 0.25mg tablets according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, although consistent timing is recommended.

How Etismith 0.25mg Tablet works:

Etismith 0.25mg tablets contain a benzodiazepine that enhances the effects of GABA, a neurotransmitter. This action reduces heightened and irregular neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of alcohol consumption while taking Etismith 0.25mg Tablet is undetermined. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the use of Etismith 0.25mg tablets in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Etismith 0.25mg Tablet with breastfeeding are unavailable. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Etismith 0.25mg tablets can induce adverse reactions that might compromise your driving capabilities. Sedation and musculoskeletal relaxation are frequently reported side effects of Etismith 0.25mg tablets, potentially affecting your ability to drive safely.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Etismith 0.25mg tablets in individuals with renal impairment. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Etismith 0.25mg tablets in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Etismith 0.25mg Tablet :

Should you forget a dose of Etismith 0.25mg Tablet, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Etismith 0.25mg Tablet

LabelValue
Chemical Category Thienodiazepine Analog
Developing Habits No.
Treatment Category Neuroscience Central Nervous System
Behavioral Class Benzodiazepine medications

FAQs on Etismith 0.25mg Tablet

Reports indicate Etismith 0.25mg Tablets may be abused; patients with a history of substance abuse should use this medication cautiously.
Etismith 0.25mg Tablets exhibit reduced sedative effects, lower dependence potential, and slower tolerance development compared to other benzodiazepines. Nevertheless, prolonged use can diminish efficacy and potentially lead to dependence and addiction.
Abruptly discontinuing Etismith 0.25mg tablets can trigger withdrawal, potentially manifesting as anxiety, insomnia, headache, dizziness, tinnitus, anorexia, vomiting, nausea, tremor, weakness, excessive sweating, irritability, and heightened sensitivity to light and sound. Furthermore, palpitations, tachycardia (rapid heart rate), and postural hypotension may occur. Severe, rare cases, especially following high doses, may involve seizures, psychosis, agitation, confusion, and hallucinations.
Etismith 0.25mg tablets, taken orally, start working in 30 to 60 minutes, reaching peak effectiveness in 3 to 4 hours. The effects typically last 6 to 8 hours, though this may be extended with higher doses.
While it shares the muscle relaxant property of benzodiazepines, its primary application is in treating anxiety.
Primarily prescribed for anxiety, this benzodiazepine, like others, induces drowsiness. While it extends total sleep time and reduces REM sleep, it doesn't affect the time it takes to fall asleep.
Etismith 0.25mg tablets don't treat depression; they're used for generalized anxiety disorder with depressive symptoms, though they can influence mood.
Etismith 0.25mg Tablet
30
MRP 35
14% off